EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The GLP ‐1–Mitochondria Axis in Metabolic Aging

Renin Chang iD, Andy P Tsai iD, Boyang Wang, Chia-Jung Li iD

Aging Cell · 2026-08 · 25 (8)

DOI: 10.1111/acel.70676 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Aging Cell, online erschienen am 17.08.2026. Verfasst von Renin Chang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Aging, Mitochondria, Glucagon-Like Peptide 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Kaohsiung Veterans General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic aging underlies a cluster of chronic conditions—type 2 diabetes, cardiovascular disease, sarcopenia, and neurodegeneration—that account for a substantial share of global morbidity and mortality. A common feature is progressive mitochondrial dysfunction: impaired bioenergetics, disrupted quality control, and loss of metabolic resilience. Reduced mitochondrial DNA copy number in peripheral blood leukocytes is associated with cardiometabolic disease and mortality, but pre‐analytical variability, dependence on blood‐cell composition, and uncertain relationship to tissue‐level function mean it should be regarded as a candidate risk‐associated biomarker rather than a validated measure of mitochondrial integrity. Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs), developed for glycemic control, engage pathways implicated in mitochondrial biogenesis, dynamics, and mitophagy; whether these effects reflect direct receptor signaling, indirect consequences of weight loss, or secondary mediators such as interleukin‐6 remains debated and appears tissue‐dependent. In SELECT, semaglutide reduced major adverse cardiovascular events by 20% in obesity without diabetes, and a 2025 multi‐omic study in aged male mice found GLP‐1 RA treatment attenuated age‐associated molecular signatures despite only modest changes in food intake and body weight. No trial, however, has incorporated a prespecified mitochondrial endpoint, human mechanistic evidence remains limited, and access to these therapies remains uneven worldwide. Here we synthesize mechanistic, preclinical, and clinical evidence for a proposed GLP‐1–mitochondria axis, classify this evidence by receptor dependence and translational stage, distinguish disease‐specific treatment effects from evidence for aging modification, examine four major controversies, and outline a research and policy agenda for responsible, evidence‐graded development of GLP‐1‐based geroscience interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgingMitochondriaGlucagon-Like Peptide 1HumansAnimalsSemaglutide

Stichwörter der Autor:innen

GLP‐1 receptor agonistsgerosciencehealthy agingmetabolic agingmitochondrial dysfunctionmitochondrial resiliencepopulation health

Substanzen

Glucagon-Like Peptide 1Semaglutide

Autor:innen und Institutionen

  • Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
  • Center of General Education, Cheng Shiu University, Kaohsiung, Taiwan.
  • Center of General Education, Shu-Zen Junior College of Medicine and Management, Kaohsiung, Taiwan.
  • Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.
  • Sundial Initiative, Palo Alto, California, USA.
  • Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.

ORCID-Profile: Renin Chang, Andy P Tsai, Chia-Jung Li

Förderung

  • National Science and Technology Council
  • Kaohsiung Veterans General Hospital

Zitieren

APA

Chang, R., Tsai, A. P., Wang, B., & Li, C. J. (2026). The GLP ‐1–Mitochondria Axis in Metabolic Aging. Aging Cell, 25(8). https://doi.org/10.1111/acel.70676

Vancouver

Chang R, Tsai AP, Wang B, Li CJ. The GLP ‐1–Mitochondria Axis in Metabolic Aging. Aging Cell. 2026;25(8). doi:10.1111/acel.70676

BibTeX
@article{Chang2026,
  author = {Chang, Renin and Tsai, Andy P and Wang, Boyang and Li, Chia-Jung},
  title = {The GLP ‐1–Mitochondria Axis in Metabolic Aging},
  journal = {Aging Cell},
  year = {2026},
  volume = {25},
  number = {8},
  doi = {10.1111/acel.70676}
}
Kostenlos starten →